Stocktoria
IRIDEX CORP IRIX
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1996-02-16
IRIDEX CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 36.5% | 40.1% | 42.0% | 44.5% | 42.4% |
| Operating margin | -4.9% | -17.1% | -19.3% | -13.2% | -14.0% |
| Net margin | -8.4% | -18.3% | -18.5% | -13.2% | -9.7% |
| FCF margin | -4.3% | -15.0% | -13.2% | -17.2% | 14.8% |
| Return on assets | -15.2% | -30.6% | -27.8% | -17.8% | -10.7% |
| Return on equity | -90.1% | -424.9% | -100.5% | -43.8% | -22.4% |
| Debt / equity | — | 0.48× | — | — | — |
| Current ratio | 1.91 | 1.42 | 2.12 | 2.87 | 3.34 |
| Revenue growth | 8.2% | -6.2% | -9.0% | 5.7% | 48.3% |
Source: SEC EDGAR filings · CIK 0001006045 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.